Cadmium exposure and incidence of diabetes mellitus - Results from the Malmö Diet and Cancer study

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Borné, Yan ^a   Fagerberg, Björn ^b,c   Persson, Margaretha ^a,d   Sallsten, Gerd ^e   Forsgard, Niklas ^e   Hedblad, Bo ^a   Barregard, Lars ^e   Engström, Gunnar ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CADMIUM; GLUCOSE; HEMOGLOBIN A1C; INSULIN; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BLOOD EXAMINATION; BLOOD LEVEL; CADMIUM BLOOD LEVEL; CANCER RESEARCH; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE REGISTRY; ERYTHROCYTE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HUMAN; HUMAN CELL; INCIDENCE; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; POPULATION RESEARCH; PROSPECTIVE STUDY; SMOKING; BLOOD; ENVIRONMENTAL EXPOSURE; MIDDLE AGED;

AGED; CADMIUM; DIABETES MELLITUS; ENVIRONMENTAL EXPOSURE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SMOKING;

EID: 84911494813     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112277     Document Type: Article

References (37)

1. Nordberg GF, Nogawa K, Nordberg M, Friberg LT (2007) Cadmium. In: Handbook on the Toxicology of Metals. 3rd edition (Nordberg GF, Fowler B, Nordberg M, Friberg LT, eds). Amsterdam: Elsevier, pp. 445-486.
2. The Swedish Chemical Agency. The cadmium content must be reduced - for the sake of public health (In Swedish). Teport 1/11, 2011. http://www.kemi.se/Documents/Publikationer/Trycksaker/Rapporter/KemI-Rapport-1-11.pdf.
3. Jarup L, Akesson A (2009) Current status of cadmium as an environmental health problem. Toxicol Appl Pharmacol 238: 201-208.
4. Navas-Acien A, Tellez-Plaza M, Guallar E, Muntner P, Silbergeld E, et al. (2009) Blood cadmium and lead and chronic kidney disease in US adults: a joint analysis. Am J Epidemiol 170: 1156-1164.
5. WHO (World Health Organization) (2011) Evaluation of Certain Food Additives and Contaminants. Seventy-third Report of the Joint FAO/WHO Expert Committee on Food Additives. Geneva: WHO. Available: http://whqlibdoc.who.int/trs/who-trs-960-eng.pdf. Accessed 17 March 2014.
6. Akesson A, Barregard L, Bergdahl IA, Nordberg GF, Nordberg M, et al. (2014) Non-Renal Effects and the Risk Assessment of Environmental Cadmium Exposure. Environ Health Perspect 122: 431-438.
7. Engstrom A, Michaelsson K, Suwazono Y, Wolk A, Vahter M, et al. (2011) Long-term cadmium exposure and the association with bone mineral density and fractures in a population-based study among women. J Bone Miner Res 26: 486-495.
8. Engstrom A, Michaelsson K, Vahter M, Julin B, Wolk A, et al. (2012) Associations between dietary cadmium exposure and bone mineral density and risk of osteoporosis and fractures among women. Bone 50: 1372-1378.
9. Staessen JA, Roels HA, Emelianov D, Kuznetsova T, Thijs L, et al. (1999) Environmental exposure to cadmium, forearm bone density, and risk of fractures: prospective population study. Public Health and Environmental Exposure to Cadmium (PheeCad) Study Group. Lancet 353: 1140-1144.
10. Cho YA, Kim J, Woo HD, Kang M (2013) Dietary cadmium intake and the risk of cancer: a meta-analysis. PLoS One 8:e75087.
11. International Agency for Research on Cancer (2012) Cadmium and Cadmium Compounds. IARC Monogr Eval Caracinog Risk Hum 100C. Available: http://monographs.iarc.fr/ENG/Monographs/vol100C/mono100C-8.pdf. Accessed 10 May 2014.
12. Julin B, Wolk A, Bergkvist L, Bottai M, Akesson A (2012a) Dietary cadmium exposure and risk of postmenopausal breast cancer: a population-based prospective cohort study. Cancer research 72: 1459-1466.
13. Julin B, Wolk A, Johansson JE, Andersson SO, Andren O, et al. (2012b) Dietary cadmium exposure and prostate cancer incidence: a population-based prospective cohort study. Br J Cancer 107: 895-900.
14. Fagerberg B, Bergström G, Borén J, Barregard L (2012) Cadmium exposure is accompanied by increased prevalence and future growth of atherosclerotic plaques in 64-year-old women. J Intern Med 272: 601-10.
15. Tellez-Plaza M, Navas-Acien A, Menke A, Crainiceanu CM, Pastor-Barriuso R, et al. (2012) Cadmium exposure and all-cause and cardiovascular mortality in the U.S. general population. Environ Health Perspect 120: 1017-22.
16. Tellez-Plaza M, Jones MR, Dominguez-Lucas A, Guallar E, Navas-Acien A (2013) Cadmium exposure and clinical cardiovascular disease: a systematic review. Curr Atheroscler Rep 15: 356.
17. Edwards JR, Prozialeck WC (2009) Cadmium, diabetes and chronic kidney disease. Toxicol Appl Pharmacol 238: 289-93.
18. Swaddiwudhipong W, Limpatanachote P, Nishijo M, Honda R, Mahasakpan P, et al. (2010b) Cadmium-exposed population in MaeSot district, Tak province: Associations between urinary cadmium and renal dysfunction, hypertension, diabetes, and urinary stones. J Med Assoc Thai 93: 231-238.
19. Schwartz GG, Il'yasova D, Ivanova A (2003) Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III. Diabetes Care 26: 468-70.
20. Moon SS (2013) Association of lead, mercury and cadmium with diabetes in the Korean population: the Korea National Health and Nutrition Examination Survey (KNHANES) 2009-2010. Diabet Med. 30:e143-8.
21. Swaddiwudhipong W, Mahasakpan P, Limpatanachote P, Krintratun S (2010) Correlations of urinary cadmium with hypertension and diabetes in persons living in cadmium-contaminated villages in northwestern Thailand: A population study. Environ Res 110: 612-6.
22. Barregard L, Bergström G, Fagerberg B (2013) Cadmium exposure in relation to insulin production, insulin sensitivity and type 2 diabetes: a cross-sectional and prospective study in women. Environ Res 121: 104-9.
23. Berglund G, Elmstähl S, Janzon L, Larsson SA (1993) The Malmo Diet and Cancer Study. Design and feasibility. J Intern Med 233: 45-51.
24. Borné Y, Smith JG, Melander O, Hedblad B, Engström G (2011) Red cell distribution width and risk for first hospitalization due to heart failure: a population-based cohort study. Eur J Heart Fail 13: 1355-61.
25. Melander O, Newton-Cheh C, Almgren P, Hedblad B, Berglund G, et al. (2009) Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 302: 49-57.
26. Hedblad B, Nilsson P, Janzon L, Berglund G (2000). Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-sectional study in Malmö, Sweden. Diabet Med 17: 299-307.
27. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539-53.
28. Enhörning S, Wang TJ, Nilsson PM, Almgren P, Hedblad B, et al. (2010) Plasma copeptin and the risk of diabetes mellitus. Circulation 121: 2102-8.
29. Melander O, Maisel AS, Almgren P, Manjer J, Belting M, et al. (2012) Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality. JAMA 308: 1469-75.
30. Swaddiwudhipong W, Limpatanachote P, Mahasakpan P, Krintratun S, Punta B, et al. (2012) Progress in cadmium-related health effects in persons with high environmental exposure in north western Thailand: A five-year follow-up. Environ Res 112: 194-198.
31. Kjellström T, Nordberg GF (1978) A kinetic model of cadmium metabolism in the human being. Environ Res 16: 248-69.
32. Panzer S, Kronik G, Lechner K, Bettelheim P, Neumann E, et al. (1982) Glycosylated hemoglobins (GHb): an index of red cell survival. Blood 59: 1348-50.
33. Furne JK, Springfield JR, Ho SB, Levitt MD. (2003) Simplification of the end-alveolar carbon monoxide technique to assess erythrocyte survival. J Lab Clin Med 142: 52-7.
34. Modan M, Meytes D, Rozeman P, Yosef SB, Sehayek E, et al. (1988) Significance of high HbA1 levels in normal glucose tolerance. Diabetes Care 11: 422-8.
35. Beutler E (1975) The effect of carbon monoxide on red cell life span in sickle cell disease. Blood 46: 253-9.
36. Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ (2010) Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am 39: 481-97.
37. Manjer J, Carlsson S, Elmsta˚hl S, Gullberg B, Janzon L, et al. (2001) The Malmö Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev 10: 489-99.